Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

Published Date: 13 May 2024

The study discovers that the survival rate is similar to that of the VIALE-A trial's younger patients.

Read Full News

Latest News

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

Radiation therapy for patients with breast cancer

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...

AI tool identifies women at high risk of interval breast cancer

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Study finds higher breast cancer rates in areas with more air pollution

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

Todays Updates

Adenotonsillectomy improves sleep architecture, respiratory outcomes in pediatric obstructive sleep apnea

For pediatric obstructive sleep apnea (OSA), adenotonsillectomy (T&A) significantly improves sleep architecture and respiratory outcomes, according to a study published online Oct. 24 in Laryngoscope.

'Molecular glues' and 'bumpers' offer new hope for precision medicines

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, turning the cell's busiest ...

Running 'super shoes' may make you faster—but at what cost?

Once seen only on the feet of elite runners at the Olympics and other premier running events, the so-called "super shoe" has moved from racing podiums to pavements.

Scientists find the genetic clues that let humans walk on two legs

Two small changes in human DNA may have played a big role in helping our ancestors walk upright, researchers say.

Dietary fiber, prunes and senna offer relief for constipation discomfort

Big-gun pain relievers can come with unwelcome side effects. At the top of the list for many of these products are constipation and the distress of slowed bowels.

Study finds surprising link between gut and brain rhythms

The human body is packed with natural rhythms, from your sleep-wake cycle to the steady pulsing of blood through the brain to heart rate and pulse.

Migraines and headaches are a global burden that needs greater recognition, international study finds

Modern lifestyles including stress, sedentary activity, caffeine, alcohol and poor-quality sleep remain widespread triggers for migraines and headaches, which affect more than a third of the world's population, according ...

Todays Updates

Adenotonsillectomy improves sleep architecture, respiratory outcomes in pediatric obstructive sleep apnea

For pediatric obstructive sleep apnea (OSA), adenotonsillectomy (T&A) significantly improves sleep architecture and respiratory outcomes, according to a study published online Oct. 24 in Laryngoscope.

'Molecular glues' and 'bumpers' offer new hope for precision medicines

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, turning the cell's busiest ...

Running 'super shoes' may make you faster—but at what cost?

Once seen only on the feet of elite runners at the Olympics and other premier running events, the so-called "super shoe" has moved from racing podiums to pavements.

Scientists find the genetic clues that let humans walk on two legs

Two small changes in human DNA may have played a big role in helping our ancestors walk upright, researchers say.

Dietary fiber, prunes and senna offer relief for constipation discomfort

Big-gun pain relievers can come with unwelcome side effects. At the top of the list for many of these products are constipation and the distress of slowed bowels.

Study finds surprising link between gut and brain rhythms

The human body is packed with natural rhythms, from your sleep-wake cycle to the steady pulsing of blood through the brain to heart rate and pulse.

Migraines and headaches are a global burden that needs greater recognition, international study finds

Modern lifestyles including stress, sedentary activity, caffeine, alcohol and poor-quality sleep remain widespread triggers for migraines and headaches, which affect more than a third of the world's population, according ...

Latest News

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

News All Time

Smart exercise planning could boost recovery for people with cancer

The periodization of exercise training could give people undergoing cancer treatment and those in recovery a tailored pathway to support strength and resilience during the challenging journey of cancer care and rehabilitation.

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality. Precisely predicting whether ...

Obesity-related cancer rising among both younger and older adults worldwide, study finds

A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.

mRNA-based COVID vaccines generate improved responses to immunotherapy

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Leukemia cells evade treatment by reshaping their mitochondria, researchers discover

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.

Should the UK introduce targeted prostate cancer screening? The case for and against

Former UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and tackle health inequalities ...

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...

Dense breasts: What it means and what women can do about screening

About half of women over 40 have dense breasts. The denser the breast tissue, the more difficult it is to spot cancer on a standard mammogram. Having dense breast tissue can make it harder to detect cancer and sometimes leads ...

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration of tumors into major blood vessels that cause blood clots and multiorgan failure, a one-of-a-kind ...

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong prognostic information, ...

After cancer: Study explores caring-healing modalities for survivors

As cancer survivorship rises, many people living with or beyond cancer face lasting physical and emotional challenges—particularly anxiety and depression, which affect about 30% of this population. Emotional distress is ...

Study identifies new approach to protect the brain during radiation therapy

While tremendous relief comes from successfully battling cancer, survivors can also experience cognitive impairments caused by the disease and its treatment. Up to 70% of survivors experience trouble with memory and concentration, ...

New imaging solution could help improve survival for patients with recurring prostate cancer

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has found a novel imaging solution, ...

Recommended News For You

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

New study links air pollution with higher rates of head and neck cancer

Targeted radiation therapy shows near-complete response in rare sarcoma patients

Many patients learn they could have cancer in the emergency department

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

Recommended Articles For You

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms 

Genetic Screening: A Game Changer in Cancer Prevention 

Phosphate Vs. Phosphorus: What Is The Difference? 

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

2.

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

3.

Kate Middleton Announces Major Cancer Update

4.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

5.

FDA Approves First Menin Inhibitor for Acute Leukemia

1.

Unraveling the Mysteries of Lymphoma: A Journey into the Unknown

2.

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources

3.

The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025

4.

Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment

5.

Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

5.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot